Evidence map›Paper›PMID 42791837›Full record

ArticleBioengineering (Basel, Switzerland)2026

An Efficient Spheroid Manufacturing Workflow for WJ-MSCs: Comparative Evaluation of Immediate 3D Aggregation and Conventional 2D Stabilization.

Minji Ha, Joon Ho Wang

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Minji HaDepartment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06355, Republic of Korea.ORCID 0009-0009-5732-5838
Joon Ho WangDepartment of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06355, Republic of Korea.ORCID 0000-0001-6530-795X

Funding

Ministry of Science and ICT RS-2024-00334810Ministry of Trade, Industry and Energy 20023762
6 · The paper itself

Abstract

Cryopreserved mesenchymal stem cells (MSCs) are widely used as off-the-shelf therapeutics. However, conventional manufacturing workflows typically include a post-thaw 2D monolayer recovery step before 3D spheroid formation. This study evaluated whether immediate spheroid formation following thawing (Direct-3D) could replace the conventional 2D-to-3D workflow while maintaining or improving chondrogenic potential. Using passage 5 Wharton's jelly MSCs (WJ-MSCs), spheroid morphology, early chondrogenic priming, differentiation, and extracellular matrix (ECM) formation were systematically compared between the two strategies. The Direct-3D group exhibited faster and more uniform spheroid compaction and significantly increased

Indexed as

3D cell culturecell therapy manufacturingcryopreservationearly chondrogenic primingefficiencyspheroidWharton’s jelly-derived mesenchymal stem cell

Identifiers

PMID42791837
PMCPMC13603728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.